Cumberland Pharmaceuticals (CPIX) Accounts Payables (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Accounts Payables across 17 years of filings, most recently posting $16.5 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $16.5 million, up 18.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.5 million (up 18.74% YoY), and the FY2025 annual result was $18.6 million, up 33.44% from the prior year.
• Accounts Payables came in at $16.5 million for Q1 2026 at Cumberland Pharmaceuticals, down from $18.6 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $18.6 million in Q4 2025 to a low of $10.6 million in Q2 2022.
• The 5-year median for Accounts Payables is $12.5 million (2024), against an average of $12.9 million.
• Across the five-year window, Accounts Payables slipped 6.02% in 2023 and jumped 33.44% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Accounts Payables stood at $10.8 million in 2022, then increased by 29.75% to $14.0 million in 2023, then decreased by 0.88% to $13.9 million in 2024, then surged by 33.44% to $18.6 million in 2025, then fell by 10.94% to $16.5 million in 2026.
• The last three Accounts Payables figures came in at $16.5 million (Q1 2026), $18.6 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.